Palomino Laboratories PALX
OTC PALX
$15.97 +0.65 (+4.24%)
At close: Aug 17, 2026 · 4:00 PM UTC

Palomino Laboratories (PALX) Other Accumulated Expenses (2022 - 2025)

Palomino Laboratories (PALX) posted Other Accumulated Expenses of $2740.0 for Q3 2025, down 57.85% sequentially from $6500.0 in Q2 2025, and down 93.88% YoY from $44750.0 in Q3 2024.

Palomino Laboratories (PALX) Other Accumulated Expenses (2022 - 2025) Analysis & Trends

Palomino Laboratories has reported Other Accumulated Expenses for 4 years, with the latest figure at $2740.0 in Q3 2025.

  • Quarterly Other Accumulated Expenses fell 93.88% year-over-year to $2740.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2740.0 (down 93.88% YoY) and the FY2024 annual result came in at $3140.0, down 90.19% from the prior year.
  • Other Accumulated Expenses retreated to $2740.0 in Q3 2025 per PALX's latest filing, from $6500.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $44750.0 in Q3 2024 and troughed at $2250.0 in Q1 2025.
  • A 4-year average of $20347.8 and a median of $15000.0 in 2022 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses soared 113.33% in 2023, then plunged 93.88% in 2025.
  • Over 4 years, Other Accumulated Expenses stood at $15000.0 in 2022, then jumped by 113.33% to $32000.0 in 2023, then plunged by 90.19% to $3140.0 in 2024, then declined by 12.74% to $2740.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $2740.0, $6500.0, and $2250.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2025 2,740.00
Jun 30, 2025 6,500.00
Mar 31, 2025 2,250.00
Dec 31, 2024 3,140.00
Sep 30, 2024 44,750.00
Jun 30, 2024 40,500.00
Mar 31, 2024 36,250.00
Dec 31, 2023 32,000.00
Dec 31, 2022 15,000.00